HomeCompareCME vs CAPL

CME vs CAPL: Dividend Comparison 2026

CME yields 1.75% · CAPL yields 10.21%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CME wins by $4.01M in total portfolio value· pulled ahead in Year 5
10 years
CME
CME
● Live price
1.75%
Share price
$297.58
Annual div
$5.20
5Y div CAGR
85.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.05M
Annual income
$3,278,693.93
Full CME calculator →
CAPL
CAPL
● Live price
10.21%
Share price
$20.57
Annual div
$2.10
5Y div CAGR
1.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$2,232.50
Full CAPL calculator →

Portfolio growth — CME vs CAPL

📍 CME pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMECAPL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CME + CAPL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CME pays
CAPL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CME
Annual income on $10K today (after 15% tax)
$148.53/yr
After 10yr DRIP, annual income (after tax)
$2,786,889.84/yr
CAPL
Annual income on $10K today (after 15% tax)
$867.77/yr
After 10yr DRIP, annual income (after tax)
$1,897.63/yr
At 15% tax rate, CME beats the other by $2,784,992.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CME + CAPL for your $10,000?

CME: 50%CAPL: 50%
100% CAPL50/50100% CME
Portfolio after 10yr
$2.04M
Annual income
$1,640,463.22/yr
Blended yield
80.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CME right now

CME
Analyst Ratings
13
Buy
17
Hold
5
Sell
Consensus: Hold
Price Target
$311.83
+4.8% upside vs current
Range: $300.00 — $340.00
Altman Z
0.6
Piotroski
5/9
CAPL
Analyst Ratings
6
Buy
8
Hold
1
Sell
Consensus: Hold
Altman Z
6.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CME buys
0
CAPL buys
0
No recent congressional trades found for CME or CAPL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMECAPL
Forward yield1.75%10.21%
Annual dividend / share$5.20$2.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.4%1.1%
Portfolio after 10y$4.05M$40.8K
Annual income after 10y$3,278,693.93$2,232.50
Total dividends collected$3.96M$16.0K
Payment frequencyquarterlyquarterly
SectorFinancialsStock
Analyst consensusHoldHold

Year-by-year: CME vs CAPL ($10,000, DRIP)

YearCME PortfolioCME Income/yrCAPL PortfolioCAPL Income/yrGap
1$11,024$323.97$11,732$1,032.13$708.00CAPL
2$12,414$618.83$13,698$1,144.14$1.3KCAPL
3$14,491$1,207.51$15,919$1,262.16$1.4KCAPL
4$17,948$2,442.23$18,419$1,385.93$471.00CAPL
5← crossover$24,445$5,241.07$21,223$1,515.18+$3.2KCME
6$38,525$12,368.84$24,358$1,649.62+$14.2KCME
7$74,998$33,775.95$27,852$1,788.92+$47.1KCME
8$194,178$113,930.22$31,735$1,932.73+$162.4KCME
9$718,883$511,112.41$36,037$2,080.71+$682.8KCME
10$4,047,898$3,278,693.93$40,792$2,232.50+$4.01MCME

CME vs CAPL: Complete Analysis 2026

CMEFinancials

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Full CME Calculator →

CAPLStock

CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, operation of convenience stores, and ownership and leasing of real estate used in the retail distribution of motor fuels in the United States. It operates in two segments, Wholesale and Retail. The Wholesale segment engages in the wholesale distribution of motor fuels to lessee dealers, independent dealers, commission agents, and company operated retail sites. The Retail segment is involved in the sale of convenience merchandise items; and retail sale of motor fuels at company operated retail sites and retail sites operated by commission agents. As of December 31, 2021, the company distributed motor fuel on a wholesale basis to approximately 1,750 sites located in 34 states; and owned or leased approximately 1,150 sites. CrossAmerica GP LLC operates as the general partner of the company. The company was formerly known as Lehigh Gas Partners LP and changed its name to CrossAmerica Partners LP in October 2014. The company was founded in 1992 and is based in Allentown, Pennsylvania.

Full CAPL Calculator →
📬

Get this CME vs CAPL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CME vs SCHDCME vs JEPICME vs OCME vs KOCME vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.